Cytokine gene polymorphisms and alzheimer's disease in Brazil

NeuroImmunoModulation

Volumn 20, Issue 5, 2013, Pages 239-246

  Moraes, Clayton F ^a,d   Benedet, Andrea L ^a   Souza, Vinícius C ^b   Lins, Túlio C ^c   Camargos, Einstein F ^a,e   Naves, Janeth O S ^b   Brito, Ciro J ^f   Córdova, Cláudio ^g   Pereira, Rinaldo W ^c,d,g   Nóbrega, Otávio T ^a,b  

^a Campus Universitário Darcy Ribeiro Asa Norte ^*  (Brazil)

^b Programa de Pós Graduação em Ciências da Saúde e   (United States)

^c UNIVERSITY OF BRASILIA   (Brazil)

^d UNIVERSIDADE CATÓLICA DE BRASÍLIA   (Brazil)

^e HOSPITAL UNIVERSITÁRIO DE BRASÍLIA   (Brazil)

^f FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^g Programa de Pós Graduação em Educação Física e   (Brazil)

Author keywords

Admixture; Alzheimer's disease; Cytokine; Genetic ancestry; Inflammation

Indexed keywords

APOLIPOPROTEIN E; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BRAZIL; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DNA POLYMORPHISM; FOLLOW UP; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HOMOZYGOTE; HUMAN; IMMUNOMODULATION; INHERITANCE; MAJOR CLINICAL STUDY; PHENOTYPE; POPULATION STRUCTURE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAZIL; CYTOKINES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES;

EID: 85047688738     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000350368     Document Type: Article

References (49)

1. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M: Global prevalence of dementia: a Delphi consensus study. Lancet 2005; 366: 2112-2117.
2. Castellani RJ, Rolston RK, Smith MA: Alzheimer disease. Dis Mon 2010; 56: 484-546.
3. Smith MA: Alzheimer disease. Int Rev Neurobiol 1998; 42: 1-54.
4. Gallucci Neto J, Tamelini MG, Forlenza OV: The differential diagnosis of dementia. Rev Psiquiatr Clin 2005; 32: 119-130.
5. Tuppo EE, Arias HR: The role of inflammation in Alzheimer's disease. Int J Biochem Cell Biol 2005; 37: 289-305.
6. Pasinetti GM: From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia. J Alzheimers Dis 2002; 4: 435-445.
7. Heneka MT, Kummer MP, Weggen S, Bulic B, Multhaup G, Munter L, Hull M, Pflanzner T, Pietrzik CU: Molecular mechanisms and therapeutic application of NSAIDs and derived compounds in Alzheimer's disease. Curr Alzheimer Res 2011; 8: 115-131.
8. Wan Y, Wang G, Chen SD: Genetic predisposition to inflammation: a new risk factor of Alzheimer's disease. Neurosci Bull 2008; 24: 314-322.
9. Lio D, Scola L, Romano GC, Candore G, Caruso C: Immunological and immunogenetic markers in sporadic Alzheimer's disease. Aging Clin Exp Res 2006; 18: 163-166.
10. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fievet N, Barberger-Gateau P, Engelborghs S, De Deyn P, Mateo I, Franck A, Helisalmi S, Porcellini E, Hanon O, de Pancorbo MM, Lendon C, Dufouil C, Jaillard C, Leveillard T, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossu P, Piccardi P, Annoni G, Seripa D, Galimberti D, Hannequin D, Licastro F, Soininen H, Ritchie K, Blanche H, Dartigues JF, Tzourio C, Gut I, Van Broeckhoven C, Alperovitch A, Lathrop M, Amouyel P: Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 2009; 41: 1094-1099.
11. Moraes CF, Lins TC, Carmargos EF, Naves JO, Pereira RW, Nobrega OT: Lessons from genome-wide association studies findings in Alzheimer's disease. Psychogeriatrics 2012; 12: 62-73.
12. Almkvist O, Winblad B: Early diagnosis of Alzheimer dementia based on clinical and biological factors. Eur Arch Psychiatry Clin Neurosci 1999; 249: 3-9.
13. Choudhry S, Coyle NE, Tang H, Salari K, Lind D, Clark SL, Tsai HJ, Naqvi M, Phong A, Ung N, Matallana H, Avila PC, Casal J, Torres A, Nazario S, Castro R, Battle NC, Perez-Stable EJ, Kwok PY, Sheppard D, Shriver MD, Rodriguez-Cintron W, Risch N, Ziv E, Burchard EG: Population stratification confounds genetic association studies among Latinos. Hum Genet 2006; 118: 652-664.
14. Tian C, Gregersen PK, Seldin MF: Accounting for ancestry: population substructure and genome-wide association studies. Hum Mol Genet 2008; 17:R143-R150.
15. Paschou P, Ziv E, Burchard EG, Choudhry S, Rodriguez-Cintron W, Mahoney MW, Drineas P: PCA-correlated SNPs for structure identification in worldwide human populations. PLoS Genet 2007; 3: 1672-1686.
16. Drineas P, Lewis J, Paschou P: Inferring geographic coordinates of origin for Europeans using small panels of ancestry informative markers. PLoS One 2010; 5:e11892.
17. Nassir R, Kosoy R, Tian C, White PA, Butler LM, Silva G, Kittles R, Alarcon-Riquelme ME, Gregersen PK, Belmont JW, De La Vega FM, Seldin MF: An ancestry informative marker set for determining continental origin: validation and extension using human genome diversity panels. BMC Genet 2009; 10: 39.
18. Pena SD, Di Pietro G, Fuchshuber-Moraes M, Genro JP, Hutz MH, Kehdy Fde S, Kohlrausch F, Magno LA, Montenegro RC, Moraes MO, de Moraes ME, de Moraes MR, Ojopi EB, Perini JA, Racciopi C, Ribeiro-Dos-Santos AK, Rios-Santos F, Romano-Silva MA, Sortica VA, Suarez-Kurtz G: The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected. PLoS One 2011; 6:e17063.
19. Lins TC, Vieira RG, Abreu BS, Grattapaglia D, Pereira RW: Genetic composition of Brazilian population samples based on a set of twenty-eight ancestry informative SNPs. Am J Hum Biol 2010; 22: 187-192.
20. Hou CE, Yaffe K, Perez-Stable EJ, Miller BL: Frequency of dementia etiologies in four ethnic groups. Dement Geriatr Cogn Disord 2006; 22: 42-47.
21. Murrell JR, Price B, Lane KA, Baiyewu O, Gureje O, Ogunniyi A, Unverzagt FW, Smith-Gamble V, Gao S, Hendrie HC, Hall KS: Association of apolipoprotein E genotype and Alzheimer disease in African Americans. Arch Neurol 2006; 63: 431-434.
22. Venketasubramanian N, Sahadevan S, Kua EH, Chen CP, Ng TP: Interethnic differences in dementia epidemiology: global and Asia-Pacific perspectives. Dement Geriatr Cogn Disord 2010; 30: 492-498.
23. Benedet AL, Moraes CF, Camargos EF, Oliveira LF, Souza VC, Lins TC, Henriques AD, Carmo DG, Machado-Silva W, Araujo CN, Cordova C, Pereira RW, Nobrega OT: Amerindian genetic ancestry protects against Alzheimer's disease. Dement Geriatr Cogn Disord 2012; 33: 311-317.
24. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, APA, 1994.
25. Cardellini M, Perego L, D'Adamo M, Marini MA, Procopio C, Hribal ML, Andreozzi F, Frontoni S, Giacomelli M, Paganelli M, Pontiroli AE, Lauro R, Folli F, Sesti G: C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance. Diabetes Care 2005; 28: 2007-2012.
26. Cardelli M, Cavallone L, Marchegiani F, Oliveri F, Dato S, Montesanto A, Lescai F, Lisa R, De Benedictis G, Franceschi C: A genetic-demographic approach reveals male-specific association between survival and tumor necrosis factor (A/G)-308 polymorphism. J Gerontol A Biol Sci Med Sci 2008; 63: 454-460.
27. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J: A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992; 22: 396-402.
28. Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, McDermott MF, Oksenberg J, Mc-Nicholl J, Pociot F, Hardt C, D'Alfonso S: Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1999; 1: 3-19.
29. Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, McDermott MF, Oksenberg J, McNicholl J, Pociot F, Hardt C, D'Alfonso S: Cytokine gene polymorphism in human disease: on-line databases, supplement 1. Genes Immun 2001; 2: 61-70.
30. Bergholdt R, Ghandil P, Johannesen J, Kristiansen OP, Kockum I, Luthman H, Ronningen KS, Nerup J, Julier C, Pociot F: Genetic and functional evaluation of an interleukin-12 polymorphism (IDDM18) in families with type 1 diabetes. J Med Genet 2004; 41:e39.
31. Pociot F, Ronningen KS, Bergholdt R, Lorenzen T, Johannesen J, Ye K, Dinarello CA, Nerup J: Genetic susceptibility markers in danish patients with type 1 (insulin-dependent) diabetes -evidence for polygenicity in man. Danish Study Group of Diabetes in Childhood. Autoimmunity 1994; 19: 169-178.
32. Giedraitis V, He B, Huang WX, Hillert J: Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 2001; 112: 146-152.
33. Tagore A, Gonsalkorale WM, Pravica V, Hajeer AH, McMahon R, Whorwell PJ, Sinnott PJ, Hutchinson IV: Interleukin-10 (IL-10) genotypes in inflammatory bowel disease. Tissue Antigens 1999; 54: 386-390.
34. International HapMap Consortium: A haplotype map of the human genome. Nature 2005; 437: 1299-1320.
35. Donohoe GG, Salomaki A, Lehtimaki T, Pulkki K, Kairisto V: Rapid identification of apolipoprotein E genotypes by multiplex amplification refractory mutation system PCR and capillary gel electrophoresis. Clin Chem 1999; 45: 143-146.
36. Tsai HJ, Choudhry S, Naqvi M, Rodriguez-Cintron W, Burchard EG, Ziv E: Comparison of three methods to estimate genetic ancestry and control for stratification in genetic association studies among admixed populations. Hum Genet 2005; 118: 424-433.
37. Qiu C, Kivipelto M, von Strauss E: Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci 2009; 11: 111-128.
38. Schwab C, McGeer PL: Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders. J Alzheimers Dis 2008; 13: 359-369.
39. Bales KR, Du Y, Holtzman D, Cordell B, Paul SM: Neuroinflammation and Alzheimer's disease: critical roles for cytokine/Abeta-induced glial activation, NF-kappaB, and apolipoprotein E. Neurobiol Aging 2000; 21: 427-432, discussion 451-453.
40. Cohen J: A power primer. Psychol Bull 1992; 112: 155-159.
41. Liu N, Lu H, Tao F, Guo T, Liu C, Cui B, Ning G: An association of interleukin-10 gene polymorphisms with Graves' disease in two Chinese populations. Endocrine 2011; 40: 90-94.
42. Wang AH, Lam WJ, Han DY, Ding Y, Hu R, Fraser AG, Ferguson LR, Morgan AR: The effect of IL-10 genetic variation and interleukin 10 serum levels on Crohn's disease susceptibility in a New Zealand population. Hum Immunol 2011; 72: 431-435.
43. Bagnoli S, Cellini E, Tedde A, Nacmias B, Piacentini S, Bessi V, Bracco L, Sorbi S: Association of IL10 promoter polymorphism in Italian Alzheimer's disease. Neurosci Lett 2007; 418: 262-265.
44. Scassellati C, Zanardini R, Squitti R, Bocchio-Chiavetto L, Bonvicini C, Binetti G, Zanetti O, Cassetta E, Gennarelli M: Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease. Neurosci Lett 2004; 356: 119-122.
45. Schlesinger D, Grinberg LT, Alba JG, Naslavsky MS, Licinio L, Farfel JM, Suemoto CK, de Lucena Ferretti RE, Leite RE, de Andrade MP, Dos Santos AC, Brentani H, Pasqualucci CA, Nitrini R, Jacob-Filho W, Zatz M: African ancestry protects against Alzheimer's disease-related neuropathology. Mol Psychiatry 2013; 18: 79-85.
46. Depboylu C, Du Y, Muller U, Kurz A, Zimmer R, Riemenschneider M, Gasser T, Oertel WH, Klockgether T, Dodel RC: Lack of association of interleukin-10 promoter region polymorphisms with Alzheimer's disease. Neurosci Lett 2003; 342: 132-134.
47. Ramos EM, Lin MT, Larson EB, Maezawa I, Tseng LH, Edwards KL, Schellenberg GD, Hansen JA, Kukull WA, Jin LW: Tumor necrosis factor alpha and interleukin 10 promoter region polymorphisms and risk of late-onset Alzheimer disease. Arch Neurol 2006; 63: 1165-1169.
48. Faul F, Erdfelder E, Lang AG, Buchner A: G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39: 175-191.
49. Barreto SM, Kalache A, Giatti L: Does health status explain gender dissimilarity in healthcare use among older adults? Cad Saude Publica 2006; 22: 347-355.